Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

Bayer to pay $40 million to resolve U.S. whistleblower claims over three drugs

Stock Markets Sep 02, 2022 02:58PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: The logo of Bayer AG is pictured on the facade of the historical headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo
 
BAYGN
+0.54%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BAYRY
-0.03%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Jonathan Stempel

(Reuters) - Bayer AG (ETR:BAYGN) agreed to pay $40 million to settle claims over its alleged use of kickbacks and false statements related to three prescription drugs, the U.S. Department of Justice said on Friday.

The settlement arose from whistleblower lawsuits filed in 2005 and 2006 in New Jersey by Laurie Simpson, a former Bayer (OTC:BAYRY) employee who worked in its marketing department and accused the German company of violating the federal False Claims Act.

Bayer did not admit wrongdoing in agreeing to settle.

In a statement, it said the accord "reflects a business decision by the company that resolution was preferable to continuing already protracted litigation."

Bayer was accused of paying kickbacks to doctors and hospitals to induce them to use Avelox, which treats bacteria strains, and Trasylol, which controls bleeding in heart surgeries, and marketed the drugs for off-label uses that were not reasonable or necessary.

It was also accused of downplaying the risks of Trasylol and the statin drug Baycol, both of which were withdrawn from the market for safety reasons, and overstating Baycol's effectiveness.

Bayer's conduct allegedly resulted in submissions of false Medicare and Medicaid claims for Avelox and Trasylol, and fraudulently caused the Department of Defense's combat logistics support agency to renew some contracts related to Baycol.

"Such conduct undermines the integrity of federal health care programs and jeopardizes patient safety," U.S. Attorney Philip Sellinger in New Jersey said in a statement.

The Justice Department said Bayer will pay $38.9 million to the United States, and $1.1 million to 20 U.S. states and Washington, D.C., whose laws were allegedly violated.

Simpson will receive $11.1 million from settlement proceeds. The Baycol lawsuit was moved in 2008 to Minnesota.

The False Claims Act lets whistleblowers sue on behalf of the U.S. government and share in recoveries.

Bayer to pay $40 million to resolve U.S. whistleblower claims over three drugs
 

Related Articles

Today's most important initiations
Today's most important initiations By Investing.com - Nov 28, 2022

Oppenheimer initiated coverage on Butterfly Network (BFLY) with an Outperform rating and a price target of $4.50. According to the analysts, their rating is a balancing act between...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email